CPAP continues to be the standard of care in neonates < 28 weeks gestational age (GA). However there are several pathways of care supporting the use of NHF when rescue CPAP is available, as shown below:
Consensus of published expert opinion.3,8
Disclaimer: Clinical judgement is necessary to assess the appropriate treatment for an individual patient. The use of NHF therapy is not typically supported for infants with extreme prematurity, severe respiratory distress syndrome, or untreated surfactant deficiency.
The Blender Transition Kit allows patients to receive NHF therapy as an alternative to prolonged CPAP therapy without changing the circuit. The kit comes with an Optiflow Junior 2 nasal cannula, pressure manifold and an adaptor which connects to the inspiratory limb of the CPAP circuit.